scispace - formally typeset
R

Roland A. Cooper

Researcher at Dominican University of California

Publications -  35
Citations -  1960

Roland A. Cooper is an academic researcher from Dominican University of California. The author has contributed to research in topics: Plasmodium falciparum & Chloroquine. The author has an hindex of 21, co-authored 35 publications receiving 1617 citations. Previous affiliations of Roland A. Cooper include Old Dominion University.

Papers
More filters
Journal ArticleDOI

Multiple transporters associated with malaria parasite responses to chloroquine and quinine

TL;DR: This study provides specific leads for better understanding of complex drug resistances in malaria parasites by searching for single nucleotide polymorphisms in DNA encoding 49 putative transporters and in 39 housekeeping genes that acted as negative controls.
Journal ArticleDOI

Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent

TL;DR: It is proposed that the trioxane artemisinin and its derivatives are activated by heme-iron within the neutral lipid environment where they initiate oxidation reactions that damage parasite membranes.
Journal ArticleDOI

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective.

TL;DR: It is proposed that the reconstruction of the evolutionary and molecular events underlying CQR is important at many levels, including its potential to assist in the development of rational approaches to thwart future drug resistances and the use of CQ-like compounds in drug combinations for new therapeutic approaches.
Journal ArticleDOI

Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine

TL;DR: Results indicate that transmembrane segments 1, 4 and 9 of PfCRT provide important structural components of a substrate recognition and translocation domain and charge‐affecting mutations within these segments may affect the ability of Pf CRT to bind different quinoline drugs and determine their net accumulation in the DV.